Eli Lilly

Eli Lilly Cancer Drug fails during clinical trial

Eli Lilly and Co has reported failure of its experimental lung cancer drug for late-stage trial.

Sanofi and Eli Lilly Seeking Permission for Over-The-Counter Sale of Cialis

Drug manufacturers Sanofi and Eli Lilly are looking forward to seek permission from health regulators to allow over-counter sales of Cialis, the world's top-selling erectile dysfunction drug, without a prescription. A combined statement was made on Wednesday by the pharmaceutical companies.

FDA Approves Eli Lilly’s Cyramza to Treat Advanced Gastric Cancer

Drug-maker Eli Lilly and Co. has received approval from the US Food and Drug Administration for gastric cancer drug Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma. The gastric cancer drug Cyramza (ramucirumab) is a single-agent treatment for advanced gastric cancer following disease progression after initial chemotherapy.

Two Alzheimer’s Drugs Fail in Trial Phase

Two Alzheimer’s drugs under-development have failed in their clinical trials. Bapineuzumab and Solanezumab, the two drugs, have been unsuccessful in helping those patients suffering with mild to moderate dementia.

The research, published in the Jan. 23 issue of the New England Journal of Medicine, states that two novel drugs failed in improving the cognitive function of patients.